Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleA phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors.AuthorsInfante, Jeffrey; Cohen, Roger; Kim, Kevin; Burris, Howard; Curt, Gregory; Emeribe, Ugochi; Clemett, Delyth; Tomkinson, Helen; LoRusso, PatriciaPublicationInvestigational New Drugs, 2017, Vol 35, Issue 5, p576ISSN0167-6997Publication typeArticleDOI10.1007/s10637-017-0459-7